Prime Medicine (PRME) EBT Margin (2024 - 2026)

Prime Medicine (PRME) posted EBT Margin of 26718.81% for Q1 2026, down 371.1% on a QoQ basis from 5671.6% in Q4 2025, and down 2315003.0% year-over-year from N/an in Q1 2025.

Prime Medicine (PRME) EBT Margin (2024 - 2026) Analysis & Trends

Prime Medicine's EBT Margin history runs 3 years deep, the most recent figure standing at 26718.81% for Q1 2026.

  • Quarterly EBT Margin fell 2315003.0% year-over-year to 26718.81% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 11235.37% (down 597939.0% YoY) and the FY2025 annual result came in at 4408.55%, up 215806.0% from the prior year.
  • EBT Margin was 26718.81% for Q1 2026 at Prime Medicine, down from 5671.6% in the prior quarter.
  • Across five years, EBT Margin topped out at 1936.6% in Q4 2024 and bottomed at 26718.81% in Q1 2026.
  • A 3-year average of 10702.04% and a median of 6695.95% in 2025 frame the typical range for EBT Margin.
  • Annual changes were most pronounced in 2025 — EBT Margin jumped 1497288 bps — and 2026, when it sank 2315003 bps.
  • Prime Medicine's EBT Margin stood at 1936.6% in 2024, then slumped by 193 bps to 5671.6% in 2025, then sank by 371 bps to 26718.81% in 2026.
  • Business Quant data shows PRME's EBT Margin at 26718.81% in Q1 2026, 5671.6% in Q4 2025, and 10155.35% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 17.13%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 41.95%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.05%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 34.77%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Prime Medicine 525.98 Mn 525.98 Mn - -26,718.81%

Historic Data

Download Data
DateValue
Mar 31, 2026 -26,718.81%
Dec 31, 2025 -5,671.60%
Sep 30, 2025 -10,155.35%
Jun 30, 2025 -4,716.68%
Mar 31, 2025 -3,568.78%
Dec 31, 2024 -1,936.60%
Sep 30, 2024 -25,128.23%
Mar 31, 2024 -7,720.30%